← Evidence map

ArticleThe oncologist2020

Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.

Ryan H Moy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2020
2021
2022
2023
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31570517